
Overview
Jennifer Glass is a Surgical Oncologist in Atlanta, Georgia. Dr. Glass is rated as an Experienced provider by MediFind in the treatment of Breast Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
550 Peachtree Street Northeast, MedicalOfficeTower, Atlanta, GA 30308
Emory Winship Cancer Institute
Tari King is a Surgical Oncologist in Atlanta, Georgia. Dr. King has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Intraductal Papilloma, Mastectomy, and Hepato-Pancreato-Biliary Surgery.
Emory Winship Cancer Institute
Toncred Styblo is a Surgical Oncologist in Atlanta, Georgia. Dr. Styblo has been practicing medicine for over 46 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Intraductal Papilloma, and Mastectomy.
Emory Winship Cancer Institute
Cletus Arciero is a Surgical Oncologist in Atlanta, Georgia. Dr. Arciero has been practicing medicine for over 28 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Intraductal Papilloma, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer


